A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis
- DOI
- 10.1186/s13075-018-1676-y
- Published
- 2018-08-15
- Container
- Arthritis Research & Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13075-018-1676-y,
title = {A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis},
author = {Roy M. Fleischmann and Rieke Alten and Margarita Pileckyte and Kasia Lobello and Steven Y. Hua and Carol Cronenberger and Daniel Alvarez and Amy E. Bock and K. Lea Sewell},
year = {2018},
journal = {Arthritis Research \& Therapy},
doi = {10.1186/s13075-018-1676-y},
url = {https://doi.org/10.1186/s13075-018-1676-y}
}RIS
TY - JOUR TI - A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis AU - Roy M. Fleischmann AU - Rieke Alten AU - Margarita Pileckyte AU - Kasia Lobello AU - Steven Y. Hua AU - Carol Cronenberger AU - Daniel Alvarez AU - Amy E. Bock AU - K. Lea Sewell PY - 2018 JO - Arthritis Research & Therapy DO - 10.1186/s13075-018-1676-y UR - https://doi.org/10.1186/s13075-018-1676-y ER -
APA
Fleischmann, R. M., Alten, R., Pileckyte, M., Lobello, K., Hua, S. Y., Cronenberger, C., Alvarez, D., Bock, A. E., & Sewell, K. L. (2018). A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-018-1676-y
Source records
- crossref · retrieved 2026-09-26T10:35:14.535Z